Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healagenics was a biotechnology and medical device company focused on the development of advanced wound care solutions. The company's core technology centered on a proprietary, bio-active, collagen-based scaffold designed to facilitate the healing of chronic and non-healing wounds. This scaffold, known as Healagen, was engineered to mimic the natural extracellular matrix, providing a structural framework that promotes cellular infiltration and tissue regeneration. Founded by experts in wound healing from Virginia Commonwealth University, Healagenics aimed to address significant unmet needs in the treatment of diabetic foot ulcers and venous leg ulcers. Although the company made strides in early-stage development, it is currently inactive and no longer maintains active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healagenics.